Budziszewska Bogusława, Jaworska-Feil Lucylla, Tetich Magdalena, Basta-Kaim Agnieszka, Kubera Marta, Leśkiewicz Monika, Lasoń Władysław
Department of Endocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.
Pol J Pharmacol. 2002 Nov-Dec;54(6):711-6.
In order to test if antidepressant drugs can directly influence corticotropin-releasing hormone (CRH) gene expression, their effect on CRH gene promoter activity was evaluated in neuro-2A cells stably transfected with a human CRH - chloramphenicol acetyl-transferase plasmid. Forskolin (an activator of adenylate cyclase), but not phorbol 12-myristate 13-acetate (an activator of protein kinase C), ca. 3-fold increased reporter gene activity, which confirms the critical role of the cAMP-responsive element in regulation of the CRH gene. Imipramine and fluoxetine present in the medium for 5 days, in a concentration-dependent manner (3-30 microM) inhibited the basal activity of CRH gene promoter, while tianeptine was inactive. The obtained results indicate that inhibition of the human CRH gene promoter activity by imipramine and fluoxetine, but not tianeptine, may play a role in a mechanism by which the former drugs attenuate HPA axis activity.
为了测试抗抑郁药物是否能直接影响促肾上腺皮质激素释放激素(CRH)基因表达,在稳定转染了人CRH-氯霉素乙酰转移酶质粒的Neuro-2A细胞中评估了它们对CRH基因启动子活性的影响。福斯高林(一种腺苷酸环化酶激活剂)可使报告基因活性增加约3倍,而佛波酯12-肉豆蔻酸酯13-乙酸酯(一种蛋白激酶C激活剂)则无此作用,这证实了cAMP反应元件在CRH基因调控中的关键作用。培养基中存在5天的丙咪嗪和氟西汀以浓度依赖性方式(3-30μM)抑制CRH基因启动子的基础活性,而噻奈普汀则无活性。所得结果表明,丙咪嗪和氟西汀而非噻奈普汀对人CRH基因启动子活性的抑制可能在前者药物减弱HPA轴活性的机制中起作用。